Evidence map›Paper›PMID 40855809›Full record

ReviewCurrent medicinal chemistry2025

Salvage Structures, Known as Iron Chelating Agents, Acquired from the Nature and Matured in the Labs.

Salime Lavian, Fatemeh Haddadi, Ehsan Farshadfar, Lotfollah Saghaie Dehkordi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Salime LavianDepartment of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medicinal Science, Isfahan, Iran.
Fatemeh HaddadiDepartment of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medicinal Science, Isfahan, Iran.
Ehsan FarshadfarDepartment of Chemistry, Razi University, Kermanshah, Iran.
Lotfollah Saghaie DehkordiDepartment of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medicinal Science, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron, as an essential element, plays a crucial role in ensuring the proper functioning of all living organisms. While the appropriate level of iron for the optimal functioning of organisms cannot be disregarded, an excessive amount of this element can be detrimental and give rise to various issues. Nonetheless, the condition of iron accumulation is exceedingly uncommon in the majority of individuals due to the presence of biological autoregulation systems. However, in certain genetic disorders, such as β - thalassemia major, sickle cell anemia, and others, the nature of the diseases or treatment procedures can lead to an overload of iron. Furthermore, numerous studies have substantiated the role of iron in exacerbating conditions in some non-iron-dependent disorders, such as cardiovascular diseases, cancer, malaria, and microbial infections. For the past few decades, iron-chelating agents have been employed to enhance the quality of life for patients with iron accumulation conditions. This review attempts to express the importance of natural and artificial iron chelating agents, as well as the necessity of their extraction, production, and use in vital situations. It also provides a brief overview of the paths pursued by researchers in these fields to introduce suitable compounds as practical iron scavengers for entry into the pharmaceutical market.

Indexed as

Biological ProductsIron Chelating AgentsAnimalsHumansIronIron OverloadBiological ProductsIronIron Chelating Agentscardiovascular.cytotoxicityHPOshydroxypridinoneIron chelating agentsiron overloadiron scavengermalariamicrobial infectionsiderophore

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.